SecBot SecBot
6-K ·Filed Nov 12, 2026

GMAB

GENMAB A/S
NEUTRAL
Impact 2/10
Horizonimmediate Processed4d 15h ago SEC0001434265-26-000150
Notable filing: 6-K
Actionable Insight • Neutral

The CEO's sale of 22,000 shares (3.3% of his holding) is a routine portfolio diversification, not a signal of deteriorating fundamentals. The CFO and other executives also sold modest amounts. Two board members exercised warrants at prices well below market, indicating long-term alignment. No financial results were released; monitor the next periodic report for operational performance.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$51.74
T+0 close · Nov 12, 2026 · via day close
Latest settled
−0.72%
T+1 · $51.37
Vs SPY
−0.35%
α at T+1
Next horizon
T+5
in 2d
  1. T+0 · Nov 12 $51.74entry
  2. T+1 · 4d ago −0.72%α −0.35% · $51.37
  3. T+2 · todayOpen
  4. T+5 · in 2d Pending
  5. T+20 · in 24d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Genmab filed a Form 6-K disclosing insider share transactions by the CEO, CFO, Chief Development Officer, Chief People Officer, and several board members on November 10, 2026. The CEO sold 22,000 shares at an average price of DKK 3,633.75, reducing his holding from 668,024 to 646,024 shares. The CFO sold 2,100 shares. Two board members exercised warrants to subscribe for shares. This is a routine regulatory disclosure of insider trades, not a periodic results release.

Key Facts

  • CEO Jan van de Winkel sold 22,000 shares at avg DKK 3,633.75 on Nov 10, 2026, reducing holding from 668,024 to 646,024 shares.
  • CFO Anthony Pagano sold 2,100 shares at avg DKK 3,670.29 on Nov 10, 2026.
  • EVP & Chief Development Officer Judith Klimovsky sold 1,265 shares at avg DKK 3,634.01.
  • EVP & Chief People Officer Christopher Cozic sold 3,854 shares at avg DKK 3,667.20.
  • Board members Pernille Erenbjerg (2,500 shares), Mijke Zachariasse (200 shares), and Gina Schweizer (200 shares) also sold shares.
  • Board members Martin Schultz (617 shares at DKK 1,615) and Mijke Zachariasse (351 shares at avg DKK 2,137.31) exercised warrants to subscribe for shares outside the market.
  • No periodic financial results were included in this filing.

Financial Impact

CEO sold shares worth approximately DKK 80M ($11.3M); total insider sales of approximately 32,000 shares worth roughly DKK 117M ($16.5M).

insider holdings

Risk Factors

  • Insider sales, while routine, may be perceived negatively by some market participants.
  • No financial data in this filing; the next quarterly results will determine the fundamental outlook.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
80% bullish (25 analysts)

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001434265-26-000150
Document: gmab_20261112x6kx1.htm0001434265-26-000150
Document: 0001434265-26-000150-index-headers.html0001434265-26-000150
Document: 0001434265-26-000150-index.html0001434265-26-000150
Document: 0001434265-26-000150.txt0001434265-26-000150
Earnings Context (Synthetic; results releases only)0001434265-26-000150

Track record

31 reports on GMAB

Performance horizon

3 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +91.28% at T+60 after the Aug 6, 2026 report. 5 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $52.12 Now $51.57 −1.06% settles Dec 15
  2. Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
  3. Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
  4. Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
  5. Nov 12, 20264d ago 6-K Neutral 2/10 Viewing Entry $51.74 Now $51.57 −0.33% settles Dec 11
  6. Nov 10, 20266d ago 6-K Neutral 2/10 Entry $53.87 Now $51.57 −4.27% settles Dec 10
  7. Nov 10, 20266d ago 144 Neutral 2/10 Entry $54.07 Now $51.57 −4.62% settles Dec 9
  8. Nov 5, 202611d ago 6-K Neutral 5/10 Entry $52.74 Now $51.57 −2.22% settles Dec 4
  9. Nov 4, 202612d ago Institutional Cluster Neutral 2/10 Entry $52.74 Now $51.57 −2.22% settles Dec 4
  10. Oct 28, 202619d ago 6-K Bullish 6/10 Entry $57.29 Now $51.57 −9.98% settles Nov 25
Showing 10 of 31

US Market Status

Market Closed · Opens in 9h 1m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026